Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Community outreach may boost PrEP interest in High-Risk groups

NCT ID NCT05949814

Knowledge-focused Sponsor: Centre de santé sexuelle Le 190 Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested how acceptable HIV pre-exposure prophylaxis (PrEP) is among men who have sex with men and transgender individuals who agreed to HIV/STI testing through a community-based outreach program, both online and in person. Researchers recruited 209 participants via a geolocation app or community venues. The goal was to see how many people who were eligible for PrEP actually accepted it one month later.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help design better community-based programs to increase PrEP uptake and reduce HIV transmission among high-risk groups.
What could go wrong
This is a completed observational study with 209 participants, so results may not apply to broader populations or other settings. It measures acceptability, not actual PrEP effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

209 people

The number who actually took part.

Started

Jul 2023

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Men who have sex with men (MSM) and transgender (TG) individuals

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Cisgender men, transgender men, and transgender women reporting sexual relations with men * Age 18 years old * Accepting an STIs screening after contact through a geolocated community application or a physical place of community sociability * Given oral non-opposition to the anonymized use of the collected data Exclusion Criteria: * Planned stay in France \<1 month * Person under legal guardianship

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV infections are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

sexually transmitted disease HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV infections STI

Contacts and locations

Locations

  • Le SPOT

    Paris, Île-de-France Region, 75011, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.